Andrew Kozlov
Managing Partner @ 4BIO Capital
London, United Kingdom
Andrew Kozlov is a Series A investor at 4BIO Capital in London focused on Biotechnology and Medical. Andrew Kozlov - Managing Partner @ 4BIO Capital
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Andrew Kozlov invests in
Stages Andrew Kozlov invests in
Countries Andrew Kozlov invests in
Investment Focus
Industry
- Biotechnology 2 (100%)
- Medical 1 (50%)
- Consulting 1 (50%)
- Therapeutics 1 (50%)
- Manufacturing 1 (50%)
Stage
- Series A 1 (50%)
- Funding Round 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ascend Gene & Cell Therapies
|
Ascend Gene & Cell Therapies supports manufacturing and process development projects from design through to clinical and commercial scales. They partner with biotechnology teams to embed scalable manufacturing in their operations from the beginning. They respond to customer inquiries by phone and contact form. | $65.9M / Series A / Mar 20, 2023 | |
IAG, Image Analysis Group
|
IAG, imaging expert company helps to accelerate novel drug development by using the right analytical tools and modern trial infrastructure. This includes bringing AI, Machine Learning and smart image analysis methods to ensure the speed and cost-effectiveness, while delivering true insights about your mechanism of action and patients’ response, inreal-time. | $5.2M / Apr 30, 2015 |
Co-Investors
Abingworth
2 deals together
DCVC Bio
2 deals together
Ajinomoto
1 deal together
Cathay Health
1 deal together
Deerfield Capital Management
1 deal together
Digitalis Ventures
1 deal together
About 4BIO Capital
4BIO Ventures is a London-based firm investing in venture capital and public equities in life sciences. They are focused on advanced therapies addressing high unmet medical and social needs.4BIO Capital Partners is an emerging asset manager focusing on private equity and venture capital in high growth and high return segments of biotech -biologics, gene and cell therapy and bioinformatics.
4BIO Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Andrew Kozlov
Managing Partner
|
|||
Dmitry Kuzmin
Managing Partner
|
|||
Kieran Mudryy
Partner
|
|||
Owen Smith
Principal
|
|||
Vasily Fedorin
Principal
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Andrew Kozlov invest in?
Andrew Kozlov invests primarily in Biotechnology, Medical and Consulting startups, most often at Series A and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Andrew Kozlov last invest?
The most recent investment recorded for Andrew Kozlov closed in Mar 2023. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
